Suppr超能文献

双氢睾酮激活 LNCaP 前列腺癌细胞中的 AP-1。

Dihydrotestosterone activates AP-1 in LNCaP prostate cancer cells.

机构信息

Department of Medical Biochemistry and Molecular Biology, Saarland University Medical Faculty, D-66421 Homburg, Germany.

Department of Medical Biochemistry and Molecular Biology, Saarland University Medical Faculty, D-66421 Homburg, Germany.

出版信息

Int J Biochem Cell Biol. 2019 May;110:9-20. doi: 10.1016/j.biocel.2019.02.005. Epub 2019 Feb 19.

Abstract

A cross-talk between androgen/androgen receptor signaling and the AP-1 transcription factor has been proposed. In this study, we asked whether activation of AP-1 modifies androgen-responsive gene transcription, and whether androgens effect AP-1-regulated gene transcription. We show that activation of AP-1 via expression of a constitutively active mutant of mitogen-activated/extracellular signal responsive kinase kinase (MEK) kinase-1 did not increase the activity of the androgen-responsive probasin promoter. Likewise, expression of a constitutively active mutant of the transcription factor c-Jun, which is a major constitutent of AP-1, did not increase the activity of the probasin promoter. In contrast, 5α-dihydrotestosterone (DHT) activated both the probasin promoter and the AP-1-regulated collagenase promoter in LNCaP prostate cancer cells. The AP-1 binding site within the collagenase promoter was identified as DHT-responsive element. In line with this, DHT increased the activities of the c-Jun promoter and the tumor necrosis factor alpha promoter, which both contain AP-1 binding sites. The signal transduction pathway coupling DHT stimulation with AP-1 activation required c-Jun, MAP kinases and androgen receptors, but was independent of transient receptor potential melastatin-8 (TRPM8) channels, proposed to function as ionotropic testosterone receptors. Expression of the GTPase activating protein RGS2 attenuated DHT-induced activation of AP-1, indicating that the DHT-induced signaling cascade involves G proteins.

摘要

已经有人提出,雄激素/雄激素受体信号与 AP-1 转录因子之间存在串扰。在这项研究中,我们询问了 AP-1 的激活是否会改变雄激素反应性基因的转录,以及雄激素是否会影响 AP-1 调节的基因转录。我们发现,通过表达组成型激活的丝裂原激活/细胞外信号响应激酶激酶(MEK)激酶-1 来激活 AP-1,不会增加雄激素反应性前列腺特异性抗原启动子的活性。同样,表达转录因子 c-Jun 的组成型激活突变体,而 c-Jun 是 AP-1 的主要组成部分,也不会增加前列腺特异性抗原启动子的活性。相比之下,5α-二氢睾酮(DHT)可激活前列腺癌细胞系 LNCaP 中的前列腺特异性抗原启动子和 AP-1 调节的胶原酶启动子。胶原酶启动子内的 AP-1 结合位点被鉴定为 DHT 反应元件。与此一致的是,DHT 增加了 c-Jun 启动子和肿瘤坏死因子-α启动子的活性,这两个启动子都含有 AP-1 结合位点。将 DHT 刺激与 AP-1 激活偶联的信号转导途径需要 c-Jun、MAP 激酶和雄激素受体,但不依赖于瞬时受体电位 melastatin-8(TRPM8)通道,该通道被认为是离子型睾酮受体。GTP 酶激活蛋白 RGS2 的表达减弱了 DHT 诱导的 AP-1 激活,表明 DHT 诱导的信号级联涉及 G 蛋白。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验